|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.26 USD | +3.07% |
|
+26.68% | +31.30% |
| 12:35pm | HSBC Adjusts Walgreens Boots Alliance's Price Target to $10 From $7.60, Keeps Reduce Rating | MT |
| 13/01 | Jefferies Adjusts Walgreens Boots Alliance Price Target to $11 From $9 | MT |
| Capitalization | 1.03TCr 998.93Cr 940.16Cr 843.28Cr 1.48TCr 89TCr 1.66TCr 12TCr 4.26TCr 36TCr 3.86TCr 3.78TCr 1,62500Cr | P/E ratio 2025 * |
-18.3x | P/E ratio 2026 * | -79.3x |
|---|---|---|---|---|---|
| Enterprise value | 1.77TCr 1.72TCr 1.62TCr 1.45TCr 2.54TCr 1,53200Cr 2.86TCr 20TCr 7.34TCr 63TCr 6.64TCr 6.5TCr 2,79800Cr | EV / Sales 2025 * |
0.12x | EV / Sales 2026 * | 0.11x |
| Free-Float |
60.68% | Yield 2025 * |
8.4% | Yield 2026 * | 8.4% |
More valuation ratios
* Estimated data
More news
Last Transcript: Walgreens Boots Alliance, Inc.
More recommendations
More press releases
More news
| 1 day | +3.07% | ||
| 1 week | +26.68% | ||
| Current month | +31.30% | ||
| 1 month | +20.33% | ||
| 3 months | +36.11% | ||
| 6 months | +4.70% | ||
| Current year | +31.30% |
1 week
9.20
12.35
1 month
9.0712.35
Current year
9.0712.35
1 year
8.0823.77
3 years
8.0854.35
5 years
8.0857.05
10 years
8.0897.30
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 23/10/2023 | |
Manmohan Mahajan
DFI | Director of Finance/CFO | 46 | 27/07/2023 |
Neal Sample
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/10/2023 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefano Pessina
CHM | Chairman | 84 | 15/03/2021 |
Jan Babiak
BRD | Director/Board Member | 67 | 01/04/2012 |
| Director/Board Member | 70 | 01/10/2006 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +3.07% | +26.68% | -46.44% | -77.44% | 1.03TCr | ||
| +3.09% | +4.03% | -11.94% | -56.04% | 1.13TCr | ||
| +2.77% | +4.70% | -8.99% | -50.74% | 671.25Cr | ||
| -2.51% | -2.98% | -18.08% | +59.87% | 572.22Cr | ||
| -1.03% | -1.39% | +19.13% | +19.45% | 460.6Cr | ||
| +1.19% | +1.53% | -15.32% | - | 408.62Cr | ||
| +0.91% | +0.74% | -26.19% | -23.26% | 400.17Cr | ||
| +0.54% | +6.25% | -10.26% | -35.31% | 281.12Cr | ||
| -2.43% | -7.52% | +13.01% | +77.41% | 269.83Cr | ||
| +4.43% | -4.77% | -6.09% | +8.96% | 234.26Cr | ||
| Average | +0.97% | +0.94% | -11.12% | -8.57% | 545.82Cr | |
| Weighted average by Cap. | +1.45% | +3.91% | -15.82% | -25.77% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 15TCr 15TCr 14TCr 12TCr 22TCr 13,09600Cr 24TCr 1,69300Cr 63TCr 5,36900Cr 57TCr 56TCr 23,91800Cr | 15TCr 15TCr 14TCr 13TCr 22TCr 13,34800Cr 25TCr 1,72600Cr 64TCr 5,47200Cr 58TCr 57TCr 24,37900Cr |
| Net income | -71Cr -69Cr -65Cr -58Cr -101.72Cr -6.13TCr -114.45Cr -792.72Cr -293.83Cr -2.51TCr -265.92Cr -260.23Cr -11TCr | -25Cr -24Cr -23Cr -21Cr -36Cr -2.18TCr -41Cr -281.37Cr -104.29Cr -892.19Cr -94Cr -92Cr -3.97TCr |
| Net Debt | 741.73Cr 720.51Cr 678.12Cr 608.25Cr 1.06TCr 64TCr 1.2TCr 8.3TCr 3.08TCr 26TCr 2.78TCr 2.72TCr 1,17200Cr | 731.82Cr 710.89Cr 669.07Cr 600.12Cr 1.05TCr 63TCr 1.18TCr 8.19TCr 3.04TCr 26TCr 2.75TCr 2.69TCr 1,15700Cr |
More financial data
* Estimated data
Employees
2,52,500
Sector
Drug Retailers
Calendar
30/01/2025
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/25/15 | 12.25 $ | +2.94% | 19,027,199 |
| 13/25/13 | 11.90 $ | +1.19% | 36,278,262 |
| 10/25/10 | 11.76 $ | +27.55% | 104,115,879 |
| 08/25/08 | 9.220 $ | -4.65% | 22,071,539 |
| 07/25/07 | 9.670 $ | +2.11% | 20,448,319 |
Delayed Quote Nasdaq, January 15, 2025 at 12:24 am IST
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
11.90USD
Average target price
11.46USD
Spread / Average Target
-3.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WBA Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition